SCISPARC: NEUROTHERA LABS ANNOUNCES INITIATION OF PHASE IIB CLINICAL TRIAL AT HANNOVER MEDICAL SCHOOL IN GERMANY FOR INNOVATIVE TREATMENT OF TOURETTE SYNDROME

Reuters · 1d ago

Please log in to view news